Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Provention Bio, Inc. - Common Stock (NQ:PRVB)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Provention Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Why Farfetch Shares Are Trading Lower; Here Are 26 Stocks Moving Premarket ↗
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares rose 58.1% to $2.45 in pre-market trading. PaxMedica entered into committed equity investment agreement for up to $20 million with Lincoln Park Capital. 
Via Benzinga
News headline image
First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles ↗
 
Via Benzinga
News headline image
Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
Tesla, Amazon, Provention Bio, Polestar, Palo Alto Networks: Musk's Court Case, Job Cuts, Earnings Pull Investor Eyeballs ↗
Major Wall Street indices closed in the red and bond yields rose on Thursday as investors and traders digested comments from a Federal Reserve official in the context of potential interest rate hikes... 
Via Benzinga
News headline image
Provention Bio: Q3 Earnings Insights ↗
Provention Bio (NASDAQ:PRVB) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Miniso Group, Monday.com And Other Big Gainers From Monday ↗
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Why Is Provention Biosciences (PRVB) Stock Up 25% Today? ↗
Provention Biosciences shares are trending after reporting earnings. PRVB stock is also up 25% on hopes of FDA approval for teplizumab. 
Via InvestorPlace
News headline image
Gold Drops Over 1%; Moderna Reports Downbeat Q3 Results ↗
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday. 
Via Benzinga
News headline image
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday ↗
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry. 
Via Benzinga
News headline image
Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session ↗
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60. 
Via Benzinga
News headline image
Crude Oil Down Over 1%; Lincoln National Shares Plunge ↗
U.S. stocks pared some losses midway through trading, with the Nasdaq Composite dropping around 80 points on Thursday. 
Via Benzinga
News headline image
US Stocks Open Lower; Nasdaq Drops 100 Points ↗
U.S. stocks traded lower this morning, with the Nasdaq Composite dropping around 100 points on Thursday. The Federal Reserve, on Wednesday, raised interest rates by 75 bps. 
Via Benzinga
News headline image
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know ↗
October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the... 
Via Benzinga
News headline image
These 2 Growth Stocks Have Potential Catalysts on the Way ↗
Both drugmakers have been outperforming the market -- which may continue if they earn important regulatory approvals soon. 
Via The Motley Fool
News headline image
Cano Health, Aehr Test Systems, Credit Suisse And Other Big Gainers From Friday ↗
U.S. stocks closed lower with the Dow Jones dropping more than 600 points on Friday. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday ↗
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued... 
Via Benzinga
News headline image
Dow Drops Over 400 Points After US Economy Adds 263,000 Jobs During September ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 400 points on Friday. 
Via Benzinga
News headline image
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday ↗
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday. 
Via Benzinga
News headline image
Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday ↗
U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Thursday. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday. 
Via Benzinga
News headline image
Dow Dips Over 300 Points; Provention Bio Shares Spike Higher ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 300 points on Thursday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday ↗
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday. 
Via Benzinga
News headline image
Why Provention Bio Shares Are Skyrocketing Today ↗
Provention Bio Inc (NASDAQ: PRVB) shares are trading higher by 20.6% to $5.97 Thursday morning after the company announced it has entered into a co-promotion agreement with Sanofi U.S. for the launch... 
Via Benzinga
News headline image
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of... 
Via Benzinga
News headline image
2 Stocks Jumping in Thursday's Premarket Trading ↗
Get an early start on the events of the day. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Statera BioPharma (NASDAQ:STAB) stock increased by 64.8% to $0.23 during Thursday's pre-market session. The company's market cap stands at $11.5 million. 
Via Benzinga
News headline image
Sanofi, Provention Bio Ink Co-Promotion Pact For Type 1 Diabetes Treatment Candidate ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022 ↗
Upgrades 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.